Retrotransposons in pluripotent cells: Impact and new roles in cellular plasticity

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 4, 2015, Pages 417-426

  Macia, Angela ^a   Blanco Jimenez, Eva ^a   García Pérez, José L ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Genome biology; Long non coding RNA; Pluripotency; Retrotransposition; Stem cell; Transposition

Indexed keywords

HOST FACTOR; RNA; RETROPOSON;

CELLULAR PLASTICITY; EMBRYO DEVELOPMENT; EPIGENETICS; HUMAN; HUMAN GENOME; NONHUMAN; PLASTICITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; RETROPOSON; REVIEW; RNA METABOLISM; TRANSPOSON; ANIMAL; CELL DEDIFFERENTIATION; GENETIC EPIGENESIS; GENETICS; MOLECULAR EVOLUTION; PHYSIOLOGY;

ANIMALS; CELL DEDIFFERENTIATION; EPIGENESIS, GENETIC; EVOLUTION, MOLECULAR; GENOME, HUMAN; HUMANS; PLURIPOTENT STEM CELLS; RETROELEMENTS;

EID: 85027930824     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.07.007     Document Type: Review

References (125)

1. McClintock B. Controlling elements and the gene. Cold Spring Harb. Symp. Quant. Biol. 1956, 21:197-216.
2. Orgel L.E., Crick F.H. Selfish DNA: the ultimate parasite. Nature 1980, 284:604-607.
3. Orgel L.E., Crick F.H., Sapienza C. Selfish DNA. Nature 1980, 288:645-646.
4. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B., Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L., Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y., Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C., Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W., Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P., Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M., Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A., Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A., Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M., Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R., Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A., Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J., Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N., Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L., Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G., Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R., Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G., Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W., Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J., Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M., McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J., Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E., Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J., Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F., Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A., Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K., Shizuya H., Choi S., Chen Y.J. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
5. Mills R.E., Bennett E.A., Iskow R.C., Devine S.E. Which transposable elements are active in the human genome?. Trends Genet. 2007, 23:183-191.
6. Goodier J.L., Kazazian H.H. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 2008, 135:23-35.
7. Munoz-Lopez M., Garcia-Perez J.L. DNA transposons: nature and applications in genomics. Curr. Genomics 2010, 11:115-128.
8. Moran J.V., Gilbert N. Mammalian LINE-1 retrotransposons and related elements. Mobile DNA II 2002, ASM Press, Washington, DC. N. Craig, R. Craggie, M. Gellert, A. Lambowitz (Eds.).
9. Maksakova I.A., Mager D.L., Reiss D. Keeping active endogenous retroviral-like elements in check: the epigenetic perspective. Cell. Mol. Life Sci. 2008, 65:3329-3347.
10. Rowe H.M., Trono D. Dynamic control of endogenous retroviruses during development. Virology 2011, 411:273-287.
11. Booth D.R., Ready P.D., Smith D.F. Evolution of multiple families of non-LTR retrotransposons in phlebotomine sandflies. Genet. Res. 1996, 67:227-237.
12. Dombroski B.A., Mathias S.L., Nanthakumar E., Scott A.F., Kazazian H.H. Isolation of an active human transposable element. Science 1991, 254:1805-1808.
13. Scott A.F., Schmeckpeper B.J., Abdelrazik M., Comey C.T., O'Hara B., Rossiter J.P., Cooley T., Heath P., Smith K.D., Margolet L. Origin of the human L1 elements: proposed progenitor genes deduced from a consensus DNA sequence. Genomics 1987, 1:113-125.
14. Beck C.R., Collier P., Macfarlane C., Malig M., Kidd J.M., Eichler E.E., Badge R.M., Moran J.V. LINE-1 retrotransposition activity in human genomes. Cell 2010, 141:1159-1170.
15. Brouha B., Schustak J., Badge R.M., Lutz-Prigge S., Farley A.H., Moran J.V., Kazazian H.H. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5280-5285.
16. Swergold G.D. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol. Cell. Biol. 1990, 10:6718-6729.
17. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol. Cell. Biol. 2001, 21:1973-1985.
18. Beck C.R., Garcia-Perez J.L., Badge R.M., Moran J.V. LINE-1 elements in structural variation and disease. Annu. Rev. Genomics Hum. Genet. 2011, 12:187-215.
19. Moran J.V., Holmes S.E., Naas T.P., DeBerardinis R.J., Boeke J.D., Kazazian H.H. High frequency retrotransposition in cultured mammalian cells. Cell 1996, 87:917-927.
20. Hohjoh H., Singer M.F. Sequence-specific single-strand RNA binding protein encoded by the human LINE-1 retrotransposon. EMBO J. 1997, 16:6034-6043.
21. Hohjoh H., Singer M.F. Ribonuclease and high salt sensitivity of the ribonucleoprotein complex formed by the human LINE-1 retrotransposon. J. Mol. Biol. 1997, 271:7-12.
22. Khazina E., Weichenrieder O. Non-LTR retrotransposons encode noncanonical RRM domains in their first open reading frame. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:731-736.
23. Martin S.L., Bushman F.D. Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol. Cell. Biol. 2001, 21:467-475.
24. Martin F., Maranon C., Olivares M., Alonso C., Lopez M.C. Characterization of a non-long terminal repeat retrotransposon cDNA (L1Tc) from Trypanosoma cruzi: homology of the first ORF with the ape family of DNA repair enzymes. J. Mol. Biol. 1995, 247:49-59.
25. Feng Q., Moran J.V., Kazazian H.H., Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996, 87:905-916.
26. Mathias S.L., Scott A.F., Kazazian H.H., Boeke J.D., Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991, 254:1808-1810.
27. Alisch R.S., Garcia-Perez J.L., Muotri A.R., Gage F.H., Moran J.V. Unconventional translation of mammalian LINE-1 retrotransposons. Genes Dev. 2006, 20:210-224.
28. Dmitriev S.E., Andreev D.E., Terenin I.M., Olovnikov I.A., Prassolov V.S., Merrick W.C., Shatsky I.N. Efficient translation initiation directed by the 900-nucleotide-long and GC-rich 5' untranslated region of the human retrotransposon LINE-1 mRNA is strictly cap dependent rather than internal ribosome entry site mediated. Mol. Cell. Biol. 2007, 27:4685-4697.
29. Wei W., Gilbert N., Ooi S.L., Lawler J.F., Ostertag E.M., Kazazian H.H., Boeke J.D., Moran J.V. Human L1 retrotransposition: cis preference versus trans complementation. Mol. Cell. Biol. 2001, 21:1429-1439.
30. Doucet A.J., Hulme A.E., Sahinovic E., Kulpa D.A., Moldovan J.B., Kopera H.C., Athanikar J.N., Hasnaoui M., Bucheton A., Moran J.V., Gilbert N. Characterization of LINE-1 ribonucleoprotein particles. PLoS Genet. 2010, 6:e1001150.
31. Goodier J.L., Zhang L., Vetter M.R., Kazazian H.H. LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol. Cell. Biol. 2007, 27:6469-6483.
32. Kulpa D.A., Moran J.V. Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum. Mol. Genet. 2005, 14:3237-3248.
33. Martin S.L. Ribonucleoprotein particles with LINE-1 RNA in mouse embryonal carcinoma cells. Mol. Cell. Biol. 1991, 11:4804-4807.
34. Luan D.D., Korman M.H., Jakubczak J.L., Eickbush T.H. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 1993, 72:595-605.
35. Cost G.J., Feng Q., Jacquier A., Boeke J.D. Human L1 element target-primed reverse transcription in vitro. EMBO J. 2002, 21:5899-5910.
36. Jurka J. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1872-1877.
37. Monot C., Kuciak M., Viollet S., Mir A.A., Gabus C., Darlix J.L., Cristofari G. The specificity and flexibility of l1 reverse transcription priming at imperfect T-tracts. PLoS Genet. 2013, 9:e1003499.
38. Grimaldi G., Skowronski J., Singer M.F. Defining the beginning and end of KpnI family segments. EMBO J. 1984, 3:1753-1759.
39. Coufal N.G., Garcia-Perez J.L., Peng G.E., Marchetto M.C., Muotri A.R., Mu Y., Carson C.T., Macia A., Moran J.V., Gage F.H. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20382-20387.
40. Gilbert N., Lutz S., Morrish T.A., Moran J.V. Multiple fates of l1 retrotransposition intermediates in cultured human cells. Mol. Cell. Biol. 2005, 25:7780-7795.
41. Ostertag E.M., Kazazian H.H. Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res. 2001, 11:2059-2065.
42. Dewannieux M., Esnault C., Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat. Genet. 2003, 35:41-48.
43. Batzer M.A., Deininger P.L. Alu repeats and human genomic diversity. Nat. Rev. Genet. 2002, 3:370-379.
44. Ostertag E.M., Goodier J.L., Zhang Y., Kazazian H.H. SVA elements are nonautonomous retrotransposons that cause disease in humans. Am. J. Hum. Genet. 2003, 73:1444-1451.
45. Hancks D.C., Goodier J.L., Mandal P.K., Cheung L.E., Kazazian H.H. Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum. Mol. Genet. 2011, 20:3386-3400.
46. Raiz J., Damert A., Chira S., Held U., Klawitter S., Hamdorf M., Lower J., Stratling W.H., Lower R., Schumann G.G. The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res. 2012, 40(4):1666-1683. (Epub 2011 Nov 3). 10.1093/nar/gkr863.
47. Bennett E.A., Keller H., Mills R.E., Schmidt S., Moran J.V., Weichenrieder O., Devine S.E. Active Alu retrotransposons in the human genome. Genome Res. 2008, 18:1875-1883.
48. Kazazian H.H., Wong C., Youssoufian H., Scott A.F., Phillips D.G., Antonarakis S.E. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 1988, 332:164-166.
49. Belancio V.P., Deininger P., Roy-Engel A.M. LINE dancing in the human genome: transposable elements and disease. Genome Med. 2009, 1:97.
50. Belancio V.P., Hedges D.J., Deininger P. Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res. 2008, 18:343-358.
51. Kazazian H.H. Mobile elements: drivers of genome evolution. Science 2004, 303:1626-1632.
52. Kazazian H.H., Moran J.V. The impact of L1 retrotransposons on the human genome. Nat. Genet. 1998, 19:19-24.
53. Hancks D.C., Kazazian H.H. Active human retrotransposons: variation and disease. Curr. Opin. Genet. Dev. 2012, 22:191-203.
54. Garcia-Perez J.L., Marchetto M.C., Muotri A.R., Coufal N.G., Gage F.H., O'Shea K.S., Moran J.V. LINE-1 retrotransposition in human embryonic stem cells. Hum. Mol. Genet. 2007, 16:1569-1577.
55. Kano H., Godoy I., Courtney C., Vetter M.R., Gerton G.L., Ostertag E.M., Kazazian H.H. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev. 2009, 23:1303-1312.
56. van den Hurk J.A., Meij I.C., Seleme M.C., Kano H., Nikopoulos K., Hoefsloot L.H., Sistermans E.A., de Wijs I.J., Mukhopadhyay A., Plomp A.S., de Jong P.T., Kazazian H.H., Cremers F.P. L1 retrotransposition can occur early in human embryonic development. Hum. Mol. Genet. 2007, 16:1587-1592.
57. Levin H.L., Moran J.V. Dynamic interactions between transposable elements and their hosts. Nat. Rev. Genet. 2011, 12:615-627.
58. An W., Han J.S., Wheelan S.J., Davis E.S., Coombes C.E., Ye P., Triplett C., Boeke J.D. Active retrotransposition by a synthetic L1 element in mice. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18662-18667.
59. Babushok D.V., Ostertag E.M., Courtney C.E., Choi J.M., Kazazian H.H. L1 integration in a transgenic mouse model. Genome Res. 2006, 16:240-250.
60. Baillie J.K., Barnett M.W., Upton K.R., Gerhardt D.J., Richmond T.A., De Sapio F., Brennan P.M., Rizzu P., Smith S., Fell M., Talbot R.T., Gustincich S., Freeman T.C., Mattick J.S., Hume D.A., Heutink P., Carninci P., Jeddeloh J.A., Faulkner G.J. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 2011, 479:534-537.
61. Coufal N.G., Garcia-Perez J.L., Peng G.E., Yeo G.W., Mu Y., Lovci M.T., Morell M., O'Shea K.S., Moran J.V., Gage F.H. L1 retrotransposition in human neural progenitor cells. Nature 2009, 460:1127-1131.
62. Evrony G.D., Cai X., Lee E., Hills L.B., Elhosary P.C., Lehmann H.S., Parker J.J., Atabay K.D., Gilmore E.C., Poduri A., Park P.J., Walsh C.A. Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell 2012, 151:483-496.
63. Muotri A.R., Chu V.T., Marchetto M.C., Deng W., Moran J.V., Gage F.H. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 2005, 435:903-910.
64. Singer T., McConnell M.J., Marchetto M.C., Coufal N.G., Gage F.H. LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes?. Trends Neurosci. 2010, 33:345-354.
65. Thomas C.A., Muotri A.R. LINE-1: creators of neuronal diversity. Front. Biosci. 2012, 4:1663-1668.
66. Thomas C.A., Paquola A.C., Muotri A.R. LINE-1 retrotransposition in the nervous system. Annu. Rev. Cell Dev. Biol. 2012, 28:555-573.
67. Miki Y., Nishisho I., Horii A., Miyoshi Y., Utsunomiya J., Kinzler K.W., Vogelstein B., Nakamura Y. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 1992, 52:643-645.
68. Iskow R.C., McCabe M.T., Mills R.E., Torene S., Pittard W.S., Neuwald A.F., Van Meir E.G., Vertino P.M., Devine S.E. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 2010, 141:1253-1261.
69. Lee E., Iskow R., Yang L., Gokcumen O., Haseley P., Luquette L.J., Lohr J.G., Harris C.C., Ding L., Wilson R.K., Wheeler D.A., Gibbs R.A., Kucherlapati R., Lee C., Kharchenko P.V., Park P.J. Landscape of somatic retrotransposition in human cancers. Science 2012, 337:967-971.
70. Shukla R., Upton K.R., Munoz-Lopez M., Gerhardt D.J., Fisher M.E., Nguyen T., Brennan P.M., Baillie J.K., Collino A., Ghisletti S., Sinha S., Iannelli F., Radaelli E., Dos Santos A., Rapoud D., Guettier C., Samuel D., Natoli G., Carninci P., Ciccarelli F.D., Garcia-Perez J.L., Faivre J., Faulkner G.J. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 2013, 153:101-111.
71. Solyom S., Ewing A.D., Rahrmann E.P., Doucet T., Nelson H.H., Burns M.B., Harris R.S., Sigmon D.F., Casella A., Erlanger B., Wheelan S., Upton K.R., Shukla R., Faulkner G.J., Largaespada D.A., Kazazian H.H. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 2012, 22:2328-2338.
72. Carreira P.E., Richardson S.R., Faulkner G.J. L1 retrotransposons, cancer stem cells and oncogenesis. FEBS J. 2014, 281(1):63-73. (Epub 2013 Nov 28). 10.1111/febs.12601.
73. Munoz-Lopez M., Medina P.P., Garcia-Perez J.L. Wiping DNA methylation: Wip1 regulates genomic fluidity on cancer. Cancer Cell 2013, 24:405-407.
74. Goodier J.L., Cheung L.E., Kazazian H.H. Mapping the LINE1 ORF1 protein interactome reveals associated inhibitors of human retrotransposition. Nucleic Acids Res. 2013, 41:7401-7419.
75. Taylor M.S., Lacava J., Mita P., Molloy K.R., Huang C.R., Li D., Adney E.M., Jiang H., Burns K.H., Chait B.T., Rout M.P., Boeke J.D., Dai L. Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition. Cell 2013, 155:1034-1048.
76. Bourc'his D., Bestor T.H. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 2004, 431:96-99.
77. Thayer R.E., Singer M.F., Fanning T.G. Undermethylation of specific LINE-1 sequences in human cells producing a LINE-1-encoded protein. Gene 1993, 133:273-277.
78. Munoz-Lopez M., Macia A., Garcia-Canadas M., Badge R.M., Garcia-Perez J.L. An epi [c] genetic battle: LINE-1 retrotransposons and intragenomic conflict in humans. Mobile Genet. Elem. 2011, 1:122-127.
79. Shen Y., Chow J., Wang Z., Fan G. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum. Mol. Genet. 2006, 15:2623-2635.
80. Wissing S., Munoz-Lopez M., Macia A., Yang Z., Montano M., Collins W., Garcia-Perez J.L., Moran J.V., Greene W.C. Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility. Hum. Mol. Genet. 2012, 21:208-218.
81. Macia A., Munoz-Lopez M., Cortes J.L., Hastings R.K., Morell S., Lucena-Aguilar G., Marchal J.A., Badge R.M., Garcia-Perez J.L. Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol. Cell. Biol. 2011, 31:300-316.
82. Branco M.R., Ficz G., Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat. Rev. Genet. 2012, 13:7-13.
83. Faulkner G.J., Kimura Y., Daub C.O., Wani S., Plessy C., Irvine K.M., Schroder K., Cloonan N., Steptoe A.L., Lassmann T., Waki K., Hornig N., Arakawa T., Takahashi H., Kawai J., Forrest A.R., Suzuki H., Hayashizaki Y., Hume D.A., Orlando V., Grimmond S.M., Carninci P. The regulated retrotransposon transcriptome of mammalian cells. Nat. Genet. 2009, 41:563-571.
84. Rangwala S.H., Zhang L., Kazazian H.H. Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol. 2009, 10:R100.
85. Xie M., Hong C., Zhang B., Lowdon R.F., Xing X., Li D., Zhou X., Lee H.J., Maire C.L., Ligon K.L., Gascard P., Sigaroudinia M., Tlsty T.D., Kadlecek T., Weiss A., O'Geen H., Farnham P.J., Madden P.A., Mungall A.J., Tam A., Kamoh B., Cho S., Moore R., Hirst M., Marra M.A., Costello J.F., Wang T. DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape. Nat. Genet. 2013, 45:836-841.
86. Garcia-Perez J.L., Morell M., Scheys J.O., Kulpa D.A., Morell S., Carter C.C., Hammer G.D., Collins K.L., O'Shea K.S., Menendez P., Moran J.V. Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. Nature 2010, 466:769-773.
87. Kuwabara T., Hsieh J., Muotri A., Yeo G., Warashina M., Lie D.C., Moore L., Nakashima K., Asashima M., Gage F.H. Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat. Neurosci. 2009, 12:1097-1105.
88. Muotri A.R., Marchetto M.C., Coufal N.G., Oefner R., Yeo G., Nakashima K., Gage F.H. L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010, 468:443-446.
89. Yoder J.A., Walsh C.P., Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 1997, 13:335-340.
90. Heras S.R., Macias S., Caceres J.F., Garcia-Perez J.L. Control of mammalian retrotransposons by cellular RNA processing activities. Mobile Genet. Elem. 2014, 4:e28439. 10.4161/mge.28439.
91. Xiol J., Spinelli P., Laussmann M.A., Homolka D., Yang Z., Cora E., Coute Y., Conn S., Kadlec J., Sachidanandam R., Kaksonen M., Cusack S., Ephrussi A., Pillai R.S. RNA clamping by Vasa assembles a piRNA amplifier complex on transposon transcripts. Cell 2014, 157:1698-1711.
92. Brennecke J., Aravin A.A., Stark A., Dus M., Kellis M., Sachidanandam R., Hannon G.J. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell 2007, 128:1089-1103.
93. Marchetto M.C., Narvaiza I., Denli A.M., Benner C., Lazzarini T.A., Nathanson J.L., Paquola A.C., Desai K.N., Herai R.H., Weitzman M.D., Yeo G.W., Muotri A.R., Gage F.H. Differential L1 regulation in pluripotent stem cells of humans and apes. Nature 2013, 503:525-529.
94. Aravin A.A., Hannon G.J., Brennecke J. The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race. Science 2007, 318:761-764.
95. Aravin A.A., Sachidanandam R., Bourc'his D., Schaefer C., Pezic D., Toth K.F., Bestor T., Hannon G.J. A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice. Mol. Cell 2008, 31:785-799.
96. Frost R.J., Hamra F.K., Richardson J.A., Qi X., Bassel-Duby R., Olson E.N. MOV10L1 is necessary for protection of spermatocytes against retrotransposons by Piwi-interacting RNAs. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11847-11852.
97. Yang N., Kazazian H.H. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat. Struct. Mol. Biol. 2006, 13:763-771.
98. Zhang A., Dong B., Doucet A.J., Moldovan J.B., Moran J.V., Silverman R.H. RNase L restricts the mobility of engineered retrotransposons in cultured human cells. Nucleic Acids Res. 2014, 42:3803-3820.
99. Heras S.R., Macias S., Plass M., Fernandez N., Cano D., Eyras E., Garcia-Perez J.L., Caceres J.F. The Microprocessor controls the activity of mammalian retrotransposons. Nat. Struct. Mol. Biol. 2013, 20:1173-1181.
100. Ciaudo C., Jay F., Okamoto I., Chen C.J., Sarazin A., Servant N., Barillot E., Heard E., Voinnet O. RNAi-dependent and independent control of LINE1 accumulation and mobility in mouse embryonic stem cells. PLoS Genet. 2013, 9:e1003791.
101. Goodier J.L., Cheung L.E., Kazazian H.H. MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet. 2012, 8:e1002941.
102. Schumann G.G. APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition. Biochem. Soc. Trans. 2007, 35:637-642.
103. Richardson S.R., Narvaiza I., Planegger R.A., Weitzman M.D., Moran J.V. APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition. eLife 2014, 3.
104. Zhao K., Du J., Han X., Goodier J.L., Li P., Zhou X., Wei W., Evans S.L., Li L., Zhang W., Cheung L.E., Wang G., Kazazian H.H., Yu X.F. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutieres syndrome-related SAMHD1. Cell Rep. 2013, 4:1108-1115.
105. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
106. Volkman H.E., Stetson D.B. The enemy within: endogenous retroelements and autoimmune disease. Nat. Immunol. 2014, 15:415-422.
107. Wissing S., Montano M., Garcia-Perez J.L., Moran J.V., Greene W.C. Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J. Biol. Chem. 2011, 286:36427-36437.
108. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
109. Inoue H., Nagata N., Kurokawa H., Yamanaka S. iPS cells: a game changer for future medicine. EMBO J. 2014, 33:409-417.
110. Li J., Kannan M., Trivett A.L., Liao H., Wu X., Akagi K., Symer D.E. An antisense promoter in mouse L1 retrotransposon open reading frame-1 initiates expression of diverse fusion transcripts and limits retrotransposition. Nucleic Acids Res. 2014, 42:4546-4562.
111. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
112. Moran V.A., Perera R.J., Khalil A.M. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012, 40:6391-6400.
113. Brown C.J., Hendrich B.D., Rupert J.L., Lafreniere R.G., Xing Y., Lawrence J., Willard H.F. The human XIST gene: analysis of a 17kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 1992, 71:527-542.
114. Hall L.L., Carone D.M., Gomez A.V., Kolpa H.J., Byron M., Mehta N., Fackelmayer F.O., Lawrence J.B. Stable C0T-1 repeat RNA is abundant and is associated with euchromatic interphase chromosomes. Cell 2014, 156:907-919.
115. Kapusta A., Kronenberg Z., Lynch V.J., Zhuo X., Ramsay L., Bourque G., Yandell M., Feschotte C. Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs. PLoS Genet. 2013, 9:e1003470.
116. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., Schonbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y. The transcriptional landscape of the mammalian genome. Science 2005, 309:1559-1563.
117. Denoeud F., Kapranov P., Ucla C., Frankish A., Castelo R., Drenkow J., Lagarde J., Alioto T., Manzano C., Chrast J., Dike S., Wyss C., Henrichsen C.N., Holroyd N., Dickson M.C., Taylor R., Hance Z., Foissac S., Myers R.M., Rogers J., Hubbard T., Harrow J., Guigo R., Gingeras T.R., Antonarakis S.E., Reymond A. Prominent use of distal 5' transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res. 2007, 17:746-759.
118. Kunarso G., Chia N.Y., Jeyakani J., Hwang C., Lu X., Chan Y.S., Ng H.H., Bourque G. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat. Genet. 2010, 42:631-634.
119. Guttman M., Donaghey J., Carey B.W., Garber M., Grenier J.K., Munson G., Young G., Lucas A.B., Ach R., Bruhn L., Yang X., Amit I., Meissner A., Regev A., Rinn J.L., Root D.E., Lander E.S. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011, 477:295-300.
120. Kelley D., Rinn J. Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome Biol. 2012, 13:R107.
121. Fort A., Hashimoto K., Yamada D., Salimullah M., Keya C.A., Saxena A., Bonetti A., Voineagu I., Bertin N. Deep transcriptome profiling of mammalian stem cells supports a regulatory role for retrotransposons in pluripotency maintenance. Nat. Genet. 2014, 46(6):558-566. 10.1038/ng.2965.
122. Lu X., Sachs F., Ramsay L., Jacques P.E., Goke J., Bourque G., Ng H.H. The retrovirus HERVH is a long noncoding RNA required for human embryonic stem cell identity. Nat. Struct. Mol. Biol. 2014, 21:423-425.
123. Santoni F.A., Guerra J., Luban J. HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency. Retrovirology 2012, 9:111.
124. Kretz M., Webster D.E., Flockhart R.J., Lee C.S., Zehnder A., Lopez-Pajares V., Qu K., Zheng G.X., Chow J., Kim G.E., Rinn J.L., Chang H.Y., Siprashvili Z., Khavari P.A. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev. 2012, 26:338-343.
125. Hulme A.E., Kulpa D.A., Garcia-Perez J.L., Moran J.V. The impact of LINE-1 retrotransposition on the human genome. Genomic Disorders: The Genomic Basis of Disease 2006, Humana Press, Totowa, NJ. J. Lupski, P. Stankiewicz (Eds.).